文献速递血栓与止血

DASH预测规则的外部验证:一项回顾性队列研究

External validation of the DASH prediction rule: a retrospective cohort study.
PubMed 文献 · J Thromb Haemost · 2017-08-23

在827例无诱因静脉血栓栓塞症患者中验证DASH预测模型的校准与区分度,1年累积复发风险在DASH评分≤1者为3.6%,与模型预测一致;DASH评分在年龄<65岁者中表现更好,>65岁者c统计量为0.54。

要点

  • DASH评分≤1者1年累积复发风险为3.6%,与模型预测一致。
  • DASH评分在年龄<65岁者中区分度较好(c统计量0.72),>65岁者较差(0.54)。
  • >65岁患者即使DASH评分最低,复发风险仍>5%。

核心结论

  • 结果证实DASH预测模型的有效性,尤其在年轻受试者中。
  • 老年(>65岁)患者即使DASH评分最低,复发风险仍>5%。

研究设计与样本

  • 回顾性队列研究,纳入827例近端无诱因深静脉血栓或肺栓塞患者,接受足疗程维生素K拮抗剂或直接口服抗凝药(>3个月)且停药后测定D-二聚体。
  • DASH评分基于停药后D-二聚体水平及事件发生时个人特征计算,复发事件采用时间依赖分析。
  • 观察12个月和24个月复发率与DASH模型预测复发率进行比较。

主要发现

  • 共分析827例患者,其中100例(12.1%)发生客观记录的复发。
  • 与原始DASH队列相比,DASH评分≤1的「低风险」受试者比例更高(66.3% vs 51.6%,P<0.001)。
  • 2年观察与预期累积发病率的斜率为0.71(95%CI 0.51-1.45)。
  • c统计量在>65岁受试者中为0.54,在较年轻受试者中为0.72。
  • DASH评分≤1者1年累积复发风险为3.6%,与模型预测一致。

关键数值与推荐

  • DASH评分≤1者1年累积复发风险为3.6%。
  • 2年观察与预期累积发病率斜率为0.71(95%CI 0.51-1.45)。
  • c统计量:>65岁者为0.54,较年轻者为0.72。
  • DASH评分≤1的「低风险」比例:本研究66.3% vs 原始DASH队列51.6%(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials Predicting recurrences may guide therapy after unprovoked venous thromboembolism (VTE). We evaluated the DASH score in 827 patients with unprovoked VTE to verify prediction accuracy. A DASH score ≤ 1 had a cumulative recurrence risk at 1 year of 3.6%, as predicted by the model. The DASH score performed better in younger (< 65 years old) subjects. SUMMARY: Background The DASH prediction model has been proposed as a guide to identify patients at low risk of recurrence of venous thromboembolism (VTE), but has never been validated in an independent cohort. Aims To validate the calibration and discrimination of the DASH prediction model, and to evaluate the DASH score in a predefined patient subgroup aged > 65 years. Methods Patients with a proximal unprovoked deep vein thrombosis (DVT) or pulmonary embolism (PE) who received a full course of vitamin K antagonist or direct oral anticoagulant (> 3 months) and had D-dimer measured after treatment withdrawal were eligible. The DASH score was computed on the basis of the D-dimer level after therapy withdrawal and personal characteristics at the time of the event. Recurrent VTE events were symptomatic proximal or distal DVT/PE, and were analyzed with a time-dependent analysis. Observed 12-month and 24-month recurrence rates were compared with recurrence rates predicted by the DASH model. Results We analyzed a total of 827 patients, of whom 100 (12.1%) had an objectively documented recurrence. As compared with the original DASH cohort, there was a greater proportion of subjects with a 'low-risk' (≤ 1) DASH score (66.3% versus 51.6%, P < 0.001). The slope of the observed versus expected cumulative incidence at 2 years was 0.71 (95% confidence interval 0.51-1.45). The c-statistic was lower for subjects aged > 65 years (0.54) than for younger subjects (0.72). Conclusions These results confirm the validity of DASH prediction model, particularly in young subjects. The recurrence risk in elderly patients (> 65 years) was, however, > 5% even in those with the lowest DASH scores.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Tosetto A, Testa S, Martinelli I, et al. External validation of the DASH prediction rule: a retrospective cohort study. J Thromb Haemost. 2017. PMID: 28762665. doi:10.1111/jth.13781

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。